Funded Awards May

Funded Awards

 

 

PI Agency Title
Vikas Dharnidharka NIH/R01 Metagenomic shotgun microbial sequencing in post-transplant lymphoproliferative disorders (PTLD-MSMS)
Thomas Ferkol State of Missouri Genetics Program, Newborn Cystic Fibrosis-Region 3
Sarah Garwood SLCH Foundation Jennings School-Based
Keith Hruska Regeneron Mechanisms of Heart Failure in CKD
David Hunstad NIH/T32 Pediatric Infectious Diseases and Immunity Training Program
Jeffrey Magee SLCH Foundation/Research Grant New therapies for childhood cancer: Using precision medicine to target a cancer’s Achilles heel
Anthony Orvedahl Society of Pediatric Research / Physician Scientist Award Role of Autophagy in Regulating Cytokine-Induced Macrophage Cell Death and Systematic Inflammatory Responses
Zachary Vesoulis NIH/K23 Racial Disparities in Preterm Brain Injury Are Driven by Differences in Cerebral
Kristine Wylie NIH/R21/Columbia University Exploring the contribution of viral PP2A inhibition to tau pathology in Alzheimer’s
Funded Awards
Funded Grants September 2021

PI Agency Title Megan Cooper NIH/ UG3/UH3/Baylor College of Medicine Safety and Efficacy of Itacitinib in treatment of JAK/STAT gain of function disorders Amjad Horani CDI Mechanisms of Primary Ciliary Dyskinesia Cynthia Ortinau Brain & Behavior Research Foundation Association of Parental Psychological Distress with Brain and Neurodevelopment in Congenital Heart …

Funded Awards
Funded Grants August 2021

PI Agency Title Fahd Ahmad NIH/CCHMC EMS for Children: Pediatric Emergency Care Applied Research Network (PECARN)  Jonathan Cooper NIH/R56 Characterizing and testing the efficacy of AAV-mediated gene therapy in a novel CRISPR/Cas9 generated sheepmodel of Cln1 disease. Jorge Di Paola NIH/R01/Ohio State University A Reversible Aptamer Based Therapeutic to Treat …

Funded Awards
Funded Grants July 2021

PI Agency Title Mohamed Abdelbaki EIF/The Hospital for Sick Children 3CI Study: Childhood Cancer Combination Immunotherapy. Phase 1b and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers Amy Armstrong Aflac Foundation/Children’s Healthcare of Atlanta A Maintenance Protocol of Sirolimus in …